Bioinformatics analysis of the clinical significance of HLA class II in breast cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference33 articles.
1. Cancer statistics, 2021.;Siegel;CA,2021
2. Drug combinations in breast cancer therapy.;Fisusi;Pharm Nanotechnol,2019
3. Breast cancer immunotherapy: facts and hopes.;Emens;Clin Cancer Res,2018
4. HLA class II antigen-processing pathway in tumors: molecular defects and clinical relevance.;Seliger;Oncoimmunology,2017
5. Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?;Altomonte;Oncogene,2003
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of disulfidptosis-related clusters and construction of a disulfidptosis-related gene prognostic signature in triple-negative breast cancer;Heliyon;2024-06
2. Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome;Journal of Personalized Medicine;2024-05-27
3. Construction of immune-related gene pairs signature to predict the overall survival of multiple myeloma patients based on whole bone marrow gene expression profiling;Molecular Genetics and Genomics;2024-04-22
4. Molecular subtype identification and prognosis stratification based on lysosome-related genes in breast cancer;Heliyon;2024-02
5. Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine;OMICS: A Journal of Integrative Biology;2023-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3